Prevention of acute renal failure.
Acute renal failure (ARF) complicates the clinical course of many critically ill patients and significantly adds to their morbidity and mortality. Efforts to develop techniques to prevent ARF or to facilitate its resolution largely have been unsuccessful. Aggressive hydration, minimizing nephrotoxins, and maintenance of "adequate" mean arterial pressure remain the main nonpharmacologic strategies to prevent ARF in the ICU. Increasing insight into mechanisms that lead to ARF prompted investigators to evaluate the role of novel therapeutic agents in the prevention of ARF. Recent data suggest that N-acetylcysteine may reduce the incidence of ARF secondary to radio-contrast agents.
Venkataraman
Ramesh
R
The CRISMA Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Room 642A, Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA. venkataramanr@ccm.upmc.edu
D000111:Acetylcysteine / Q000627:therapeutic use; D058186:Acute Kidney Injury / Q000517:prevention & control*; D004232:Diuretics / Q000627:therapeutic use; D015259:Dopamine Agents / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D005440:Fluid Therapy; D006801:Humans; D045265:Natriuretic Peptides / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D004232:Diuretics; D015259:Dopamine Agents; D045265:Natriuretic Peptides; D013806:Theophylline; D000111:Acetylcysteine